Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/08/2003CN1446584A Addition agent of pyrithioxine hydrochloride utilized for injection
10/08/2003CN1446580A Preparation of effective component from rhodiola crenulate
10/08/2003CN1446549A Use of licorice and its extract for treating osteoporosis
10/08/2003CN1446544A Anti blocking new mateial used after surgical operation
10/08/2003CN1446543A Sea cucumber polysaccharide preparation
10/08/2003CN1446542A Compound preparation for preventing and treating typical model pneumonia and other virus infection diseases
10/08/2003CN1446541A Externally applied agent for treating psoriasis, acne tinea and diversified skin diseases with pruritus
10/08/2003CN1446540A Combination of semisolid framework preparation of progesterone
10/08/2003CN1446539A Medicine for teating oral disease
10/08/2003CN1446538A Aaalgesic prepared Chinese medicine with non-addiction and its preparing technique method
10/08/2003CN1446537A Freeze drying powder pins of methane-sulfonic acid dihydro elboline and its preparing method
10/08/2003CN1446536A Combination of semisolid framework preparation of nimodipine
10/08/2003CN1446535A Chlorhydric [R(2)-alpha-methoxyimindogen-alpha-(1-dicycloaza [2.2.2] caryl-3-group) acetonitrile control-released dosage form
10/08/2003CN1446534A Lipoidosis of Chinese herbal medicine alkaloid and its preparation
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/08/2003CN1123571C 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CN1123564C Anti-inflammatory compounds
10/08/2003CN1123345C Compsns. of treating ARDS or IRDS
10/08/2003CN1123344C Slowly-released agent of piperazine ferulate
10/08/2003CN1123343C Nicotine compsns. and method for formulation thereof
10/08/2003CN1123342C Use of inhibitors of renin-angiotension system
10/08/2003CN1123341C Liquid propanethiophenyl imidzole for expelling parasites from body of livestock and its preparing process
10/08/2003CN1123340C Antiallergic agent
10/08/2003CN1123339C Diabetes remedies
10/08/2003CN1123338C Pharmaceutical formulation of omeprazole
10/08/2003CN1123337C Liquid aqueous pharmaceutical compsns. comprising sodium alginate and potassium bicarbonate
10/07/2003US6630603 reduced-pressure distillation of a concentrated lactic acid solution having a total acid content of at least 95 wt % and a content of monomeric lactic acid of at least 80 wt %, based on the concentrated lactic acid solution, crystallization
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630590 Producing a carbostyril derivative represented by the following general formula (I):by reaction of with a tetrazole derivative represented by the following general formula (III): wherein X represents a halogen atom, and A and R are as
10/07/2003US6630589 Screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element
10/07/2003US6630587 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
10/07/2003US6630579 Complex
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630516 Application of an effective, non-toxic amount of at least one active ingredient that inhibits MMPs and promotes procollagen synthesis; especially a retinoid selected from retinol, retinal, retinoic acid, or a retinoic acid salt
10/07/2003US6630515 Urinary incontinence therapy
10/07/2003US6630514 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630509 Phenalkyloxy-phenyl derivatives
10/07/2003US6630507 Cannabinoids as antioxidants and neuroprotectants
10/07/2003US6630506 Useful as antianginal agents, and cardioprotective agents and for treating peripheral vascular disease including intermittent claudication
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630504 Phenoxyphenylheterocyclyl derivatives as SSRIs
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630502 Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
10/07/2003US6630501 Phosphinic pseudo-peptides that may be used as matrix zinc metalloprotease inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630497 For therapy of hypertension and congestive heart failure; angiotensin II antagonist
10/07/2003US6630494 Treatment for central degenerative disorders, brain power disorders, depressions, and for prophylaxis of cerebral circulatory disorders
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630491 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
10/07/2003US6630490 Purine derivative or analogue
10/07/2003US6630486 Containing calcium sulfate
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630484 6-and 7-substituted analogs of swainsonine their preparation and therapeutic use
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630482 CFTR channel activator compounds and pharmaceutical compositions containing same
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630478 Administering to patient with drug-induced peripheral neuropathy an effective quantity of a purine derivative or analogue, a tetrahydroindolone derivative or analogue, or a pyrimidine derivative or analogue
10/07/2003US6630477 Therapeutic nucleoside compound
10/07/2003US6630475 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine adenosine A2a receptor antagonists; use in the treatment of central nervous system diseases, in particular Parkinson's disease
10/07/2003US6630473 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630471 Central nervous system disorders
10/07/2003US6630470 G-CSF mimetics
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630468 Disubstituted pyrazolines and triazolines as factor Xa inhibitors
10/07/2003US6630467 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
10/07/2003US6630466 Anticholinergics which have a long-lasting effect, such as glycopyrronium bromide, tiotropium bromide or an ester of bi-or tricyclic amino alcohol such as a nortropanol
10/07/2003US6630464 Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630462 Delta agonist analgesics
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003US6630458 Teat dipping agent
10/07/2003US6630454 Method and pharmaceutical composition for the treatment of cancer
10/07/2003US6630453 Androgen derivatives and uses thereof
10/07/2003US6630452 Comprises oligo-fructose and sialyl-lactose; for increasing the amount of Bifidobacteria and inhibiting the binding of pathogenic bacteria in humans
10/07/2003US6630192 Cholesterol-free margarine of linoleic acid, lauric acid, myristic acid, and palmitic acid, and elaidic acid for food products; known under tradename Smart Balance
10/07/2003US6630178 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
10/07/2003US6630173 Mixture with antiproliferative agent
10/07/2003US6630172 Organo-metallic chelate of a metal cation and potassium sodium tartrate or ion thereof and is present in >/= one fourth of the molar amount of the metal ion
10/07/2003US6630171 Polypeptide polymers of aspartic acid and glutamic acid bearing a hydrophobic group; drug delivery; insulin carrier
10/07/2003US6630168 Dimethylacetamide in combination with methyl cellulose, hydroxypropyl methylcellulose, or carboxypolymethylene; intralesional administering
10/07/2003US6630166 Coated tablet does not crack during storage; cellulose ether, sugar, calcium phosphate excipient
10/07/2003US6630165 For sustained release; therapy
10/07/2003US6630164 Dutasteride to prevent and treat atherosclerosis
10/07/2003US6630162 Pharmaceutical formulation and its use
10/07/2003US6630157 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
10/07/2003US6630155 Thermoplastic base polymer, a solvent, a poly(lactide-co-glycolide)/polyethylene glycol block polymer
10/07/2003US6630154 Polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and methods for making same
10/07/2003US6630135 Improved method of sterilizing the field of surgery; corneal penetration enhancer
10/07/2003US6630129 Pharmaceutical formulation of fluticasone propionate
10/07/2003US6630128 Insoluble support
10/07/2003US6630124 Combination therapy with VIP antagonist
10/07/2003US6629995 Camptothecin conjugates
10/07/2003US6629970 Method of restoring endothelium of cornea
10/07/2003US6629968 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
1 ... 5319 5320 5321 5322 5323 5324 5325 5326 5327 5328 5329 5330 5331 5332 5333 5334 5335 5336 5337 5338 5339 ... 7860